Skip to main content

GreenLight Biosciences Holdings, PBC

GRNADelisted Jul 24, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001822691

GreenLight Biosciences Holdings, PBC was delisted on Jul 24, 2023; its insiders filed their last Form 4 on Jul 27, 2023; 48 institutions reported holding it in 13F filings for Q2 2023, worth $9.16M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
48
Q2 2023, −11 vs. previous quarter
13F value
$9.16M
Reported value at the end of Q2 2023
Superinvestors holding
0
At the end of Q2 2023

Superinvestors holding GRNA, Q2 2023

Go to the superinvestors tab

No superinvestor reported holding GRNA at the end of Q2 2023.

Latest insider trades

Open-market purchases and sales by GreenLight Biosciences Holdings, PBC insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 24, 2023 (view filing)4:01 PM ETJul 204 daysCormorant Asset Management, LP and 3 othersOther: (See below)SSale−9.19M$0.00$0−100.0%0 after
Aug 15, 2022 (view filing)Aug 114 daysBuilders Vision, LLC10% OwnerPPurchase+6.51M$3.92+$25.5M+41.1%22.3M after2 lots
Aug 15, 2022 (view filing)Aug 114 daysWalker Matthew AllenDirector, 10% OwnerPPurchase+63.8K$3.92+$250.0KNew position63.8K after
Aug 15, 2022 (view filing)Aug 114 daysWalker Matthew AllenDirector, 10% OwnerPPurchase+6.38M$3.92+$25.0M+40.3%22.2M after
Aug 15, 2022 (view filing)Aug 114 daysMorningside Venture Investments Ltd10% OwnerPPurchase+3.06M$3.92+$12.0M+23.8%15.9M after
Mar 17, 2022 (view filing)5:11 PM ETFeb 243 daysMorningside Venture Investments Ltd and 1 other10% OwnerPPurchase+1.00M––+7.8%13.9M afterAmended
Feb 4, 2022 (view filing)8:22 PM ETFeb 22 daysWalker Matthew Allen and 1 otherDirector, 10% OwnerPPurchase+1.50M$10.00+$15.0M+10.5%15.8M after
Feb 4, 2022 (view filing)Feb 22 daysKishore GaneshDirectorPPurchase+75.0K$10.00+$750.0K+1.3%5.82M after
Feb 4, 2022 (view filing)Feb 22 daysOBrien EricDirector, 10% OwnerPPurchase+700.0K$10.00+$7.00M+8.5%8.90M after
Feb 4, 2022 (view filing)Feb 22 daysMorningside Venture Investments Ltd10% OwnerPPurchase+1.00M––+7.8%13.9M after

Top 10 13F holders, Q2 2023

The largest institutional positions in GreenLight Biosciences Holdings, PBC at the end of Q2 2023; share changes are against Q1 2023.

See all 48 holders
Institutions holding GRNA in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Cormorant Asset Management, LP9,188,659$2.74M0.16%00.0%Unchanged
Continental Grain Co6,489,242$1.95M0.89%00.0%Unchanged
Tao Capital Management LP2,671,664$802.0K0.59%00.0%Unchanged
Hudson Bay Capital Management LP1,720,199$512.8K0.01%−49,904−2.8%Reduced
Board of Trustees of The Leland Stanford Junior University1,687,374$502.8K0.05%00.0%Unchanged
BlackRock Inc.1,565,869$466.8K0.00%−3,394,179−68.4%Reduced
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1,269,179$378.0K0.00%+564,255+80.0%Added
Vanguard Group Inc1,005,419$299.7K0.00%−460,108−31.4%Reduced
Geode Capital Management, LLC837,022$249.5K0.00%−772,277−48.0%Reduced
Crystalline Management Inc.775,000$231.0K0.16%+775,000New